Recent Hepatitis C Treatment Advances
This activity has been designed to meet the educational needs of gastroenterologists, nurse practitioners and physician assistants.
At the conclusion of this activity, participants will be able to:
- • Review treatment readiness for patients before starting therapy
• Discuss treatment considerations for patients with HCV
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 0.5 contact hours may be earned for successful completion of this activity.
Nurse Practitioner Statement
Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.
This program is accredited for 0.5 contact hours. Program ID #5645.
Physician Assistant Statement
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 7.50 AAPA Category 1 CME credits. Approval is valid for one year from 01/30/2019. PAs should only claim credit commensurate with the extent of their participation.
Disclosure of Conflicts of Interest
All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and joint provider name here have no relationships to disclose.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Barbra Cave, MSN, APRN, FNP-BC has received grant/research support from AbbVie, Conatus, Dova, Gilead, Intercept, Janssen and Takeda. She has participated on the speaker bureaus for AbbVie, Gilead, Merck, Salix (spouse- Dova and Intercept). She is a consultant for Dova Pharmaceuticals and has advisory board involvement with AbbVie, Gilead and Dova.
Christina Hanson, FNP-BC has participated on the speaker bureaus for AbbVie and Salix. She has advisory board involvement with Dova and Salix.
Barbra Cave, MSN, APRN, FNP-BC
Christina Hanson, FNP-C
Release Date: 01/30/19 Expiration Date: 01/30/20
Webcast must be viewed in its entirety to claim credit.
This activity is supported by educational grants from: American Regent, Inc., Gilead, Pfizer Inc., Prometheus Laboratories Inc., Salix Pharmaceuticals, and Synergy Pharmaceuticals Inc.